Bipin N. Savani

机构：Tennessee Oncology, Takeda (United States), Vanderbilt University Medical Center · ORCID：0000-0002-3304-9965

发表论文 936 篇 · 总被引 28426 次 · h-index 87

代表论文

• Factor XIII Deficiency: A Review of Biology, Testing, and Treatment (2026 · Clinical Hematology International · 被引 5)
• Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP / EBMT (2025 · American Journal of Hematology · 被引 3)
• Outpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical Guide (2025 · JCO Oncology Practice · 被引 3)
• Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience (2026 · Frontiers in Immunology · 被引 2)
• Longterm survival and late effects following hematopoietic cell transplantation for sickle cell disease into a modern era: A center for international blood and marrow transplant research (CIBMTR) analysis (2025 · Blood · 被引 2)
• Matching-adjusted indirect treatment comparison of A+AVD vs PET-guided ABVD in newly diagnosed advanced Hodgkin lymphoma (2026 · Future Oncology · 被引 1)